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Abstract
Dipyridamole (DIP) is a well-known pharmaceutical drug used as a coronary vasodilator and anti-platelet agent in clinics for
treating several cardiovascular diseases. Primarily, the therapeutic effects of the drug are attributed to its antioxidant
potency. In this research, we aim to declare the unknown antioxidant mechanism of DIP as well as its potent chain-breaking
antioxidant activity in polar aqueous medium inside the cells, using different experimental methods and theoretical
quantum calculations. Data demonstrated the higher antioxidant capacity of DIP against ROS and free radicals in polar cell’s
interior. DIP is capable of generating long living and noninvasive DIP
N radicals in oxidant condition that leads to an effective
‘‘chain-breaking antioxidant’’ activity. Quantum computational data indicated that DIP antioxidant has more favorable
ionization potential than trolox which means DIP has higher antioxidant activity. Also, data showed that the direct
hydrogen-transfer is not a favorable process to construct DIP
N because of high barrier energy, though electron-transfer
process can more easily to produce DIP
N+ with the lowest barrier energy. Altogether, the electron donating potency of DIP
to reduce ferric ion, having the low anodic oxidation peak potential, producing long lived stable DIP
N radicals and protecting
myoblast cells from oxidation, proposed the excellent ‘‘chain-breaking antioxidant’’ potency via electron-transfer
mechanism of this vasodilator DIP drug in polar aqueous medium.
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pyrimido-(5,4-d)pyrimidine] is a dilatation agent of coronary
artery used as a treatment for several cardiovascular diseases such
as angina pectoris and myocardial infarction [1,2]. The drug can
be easily adsorbed in the human body and entered into the blood.
It prevents blood cells called platelets from clumping together
inside the blood vessels and reversibly, inhibits platelet aggregation
and platelet-mediated thrombotic disease [3]. Platelet and vascular
stimulation leads to release of reactive oxygen species (ROS) that
are known for influencing vascular reactivity and thrombosis [4].
It has been hypothesized that the therapeutic effects of DIP are
attributed to its antioxidant potency because of having special
chemical structure [3]. The structure is shown in Figure 1.
DIP has antioxidant properties which could stabilize platelet
and vascular membranes as well as prevent the oxidation of LDL
molecules [5]. Studies have demonstrated that the drug is an
efficient chain-breaking antioxidant that inhibits lipid peroxidation
[6], scavenges superoxide and hydroxyl radicals [7,8] protects
erythrocyte Times New Roman s membranes from oxidation [9]
and promotes angiogenesis in diabetic mouse hind limb model
[10]. The affinity of DIP for lipid phase is related to the fact that it
acts as an inhibitor for membrane peroxidation [11] and also lipid
peroxidation by scavengeing hydroxyl HO
N and lipid peroxyl
ROO
N radicals in lipid phase [12,13]. Using different lipid system
models, such as micelles or monolayers including DIP, it was
indicated that DIP is abundant in lipid systems [14]. It appeared
interesting to study the direct influence of DIP on ROS protection
as to the activity is known to be dependent on membrane
surroundings [14,15]. These findings obviously indicated that the
strong antioxidant affectivity of DIP in protecting lipids from
peroxidation is associated with the higher hydrophobicity of the
compound [16]. Although this drug has been used for many years,
its mechanism of action is still unclear. However, the potent chain-
breaking antioxidant activity of DIP in polar aqueous medium
especially intracellular condition has not been reported so far. In
order to better understanding, the antioxidant potency of DIP has
been extensively studied using electrochemical oxidation reactions
in phosphate buffer, optical behavior, ferric ion reduction, potent
to produce the stable radical, intracellular (L6-myoblasts) ROS
protection against toxic hydroperoxide compounds as well as
quantum chemical computations. Data declared the higher
antioxidant capacity of DIP in polar intracellular to reduce ROS
compounds through electron transfer mechanism.
Materials and Methods
The reagents used in this work were of analytical grade that
obtained from Sigma Aldrich (diprydamol, cumene hydroperox-
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cal) and Merck (potassium ferricyanide, ferric chloride, disodium-
hydrogen phosphate dehydrate, phosphoric acid). 29,79-dichlor-
odihydrofluorescein diacetate (DCFH2-DA) was provided by
Molecular Probes (Eugene, OR). Fetal bovine serum was from
GIBCO (Grand Island, NY). Dulbecco’s modified Eagle’s medium
(DMEM), antibiotics and sterile plasticware for cell culture were
from Flow Laboratory (Irvine, UK). Water treated in a
MicroMed-TKA system (conductivity ,0.1 mSc m
21), was used
to prepare the solutions. All chemicals were used without previous
purification. Stock solution of DIP was prepared by dissolving it in
DMSO at a concentration of 10 mM. The solution was stored at
4uC in dark to avoid any decomposition.
EPR measurements
The radical DIP
N was generated by oxidation of DIP in fenton
reaction. The solution was carefully deoxygenated by bubbling
nitrogen. The solutions were drawn into glass capillaries, sealed
and then measured using an ESP300 instrument (Bruker Spectro-
spin, Karlsruhe, Germany) equipped with a high sensitivity
TM110 X-band cavity.
UV-Vis spectrophotometer method
0.5 mL of 30 mM solution of 2,2-Diphenyl-1-picrylhydrazyl
radical (DPPH
N) in DMSO was thoroughly mixed with 0.5 mL of
30 mM of DIP. DPPH is widely used to evaluate the ability of
compounds to act as free radical scavengers [17,18,19]. The
optical behavior of DIP in the presence of DPPH
N was studied for
different incubated times.
Ferric ion reduction
Iron in the +3 oxidation state (Fe
3+) is known as the ferric ion.
The process by which the ferric ion reduces to the +2 oxidation
ferrous ion state (Fe
2+) is known reducing power assessment. The
reducing power of DIP was determined by analyzing its electron
donor potency according to the method we have more recently
explained [20]. Potassium ferricyanide (1%) was shortly incubated
with different concentrations of DIP for 30 min at 50uCi n
phosphate buffered saline (PBS). After adding trichloroacetic acid
(10%) and FeCl3 (0.1%) the absorbance at 700 nm was recorded
as reducing power of DIP in PBS solution.
Cyclic voltammetry experiments
The electrochemical measurements were carried out using a
potentiostat-DropSens model mStat 400. A conventional three-
electrode cell containing a glassy carbon working electrode,
platinum wire counter electrode and Ag/AgCl (3.0 M KCl)
reference electrode were employed for the voltammetric applica-
tion. Electrochemical experiments were carried out in a conven-
tional electrochemical cell, containing 2 mL of phosphate buffer
solution and 0.1 mM of DIP. Phosphate buffered solution (pH 7.4,
0.2 M) was prepared by adding phosphoric acid in 0.2 M
Na2HPO4 solution. Voltammograms were recorded with the
potential sweeping from –0.4 to 1.0 V at different scan rates.
Cell cultures
The skeletal rat muscle L-6 myoblast cells were obtained from
the American Type Culture Collection (Rockville, MD). Cells
were seeded in 75-cm
2 flasks for tissue culture and grown in
Figure 1. Chemical structure of dipyridamole (DIP).
doi:10.1371/journal.pone.0039660.g001
Figure 2. Room temperature EPR spectrum of the DIP
N radical in
DMSO. DIP
N radicals were produced by the reaction of 10 mM
DIP with 500 mM of cumene hydroperoxide in the presence of
FeSO4 (fenton reaction). Bottom spectrum indicated all reagents
without having DIP. It should be noted that because of technical
problem it was impossible to detect DIP
N radicals in PBS. Detecting DIP
N
radicals needed to use high concentration of DIP (10 mM) whereas DIP
was completely insoluble in PBS at this concentration.
doi:10.1371/journal.pone.0039660.g002
Figure 3. Optical absorption spectra of DIP in DMSO. The
mentioned DIP and DPPH
N spectra indicate 30 mM of each compound
alone in DMSO. During 20 min, the behavior of DIP spectra followed by
adding DPPH
N radical (mentioned DIP+DPPH
N).
doi:10.1371/journal.pone.0039660.g003
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mL
21 streptomycin and 100 U mL
21 penicillin, in an atmosphere
of 5% CO2 at 37uC.
Intracellular ROS assay
Principle of the intracellular ROS evaluation was exploited via
DCF method that we have published more lately [21]. Briefly, the
cells were incubated with 10 mM DCFH2-DA in phosphate
buffered saline (PBS) at 37uC for 30 min then washed twice with
PBS (37uC ). The oxidized DCF under intracellular ROS caused
cells staining to be easily detectable by fluorimeter.
Cell viability assay
Cell viability assays were done in order to evaluate the antitoxic
capacity of DIP against cytotoxic cumene hydroperoxide (CHP)
compound. Myoblast cell samples were treated with different
concentrations of DIP for 30 min. Then cells were induced by
CHP as a powerful cytotoxic compound for 30 min. The
percentage of viable cells in the presence and absence of DIP
was determined by the methylthiazole tetrazolium (MTT) assay
[21,22].
Theoretical studies
Quantum chemical calculations were aimed to determine the
molecular geometry and energetic properties associated with
antioxidant parameters of the molecule. For this purpose, density-
functional-theory (DFT) method [23] was used to calculate
ionization potential (IP) which takes advantage of accuracy and
economy [24]. Three dimensional structure of DIP was obtained
from NCBI PubChem Compound database (CID: 3108) [25]. The
molecular geometries were first optimized by the molecular-
mechanic MM+ method and followed by the semiempirical
quantum-chemical method AM1 [26]. Then, B3LYP functional
on basis sets of (U)B3LYP/6-31G(d) and RO)B3LYP/6–31G(d)
was used to calculate the single-point energy (SPE). UB3LYP and
ROB3LYP refer to the unrestricted Open-Shell and restricted
Open-Shell calculation that used for the radical generated after
electron-abstraction (cation radicals) and H-abstraction respec-
tively. The molecular energy consists of (U)B3LYP/6-31G(d)-
calculated SPE and AM1-calculated zero-point vibration energy
(ZPVE, scaled by a factor of 0.973) [24,27]. The ionization
Figure 4. Electron donating capacity of DIP and trolox (Tox) to
ferric iron (Fe
3+) reduction. The absorbance at 700 nm was recorded
as a function of DIP and Tox concentrations in phosphate buffered
saline (PBS) to monitor the reduction of ferric ion to ferrousion.
doi:10.1371/journal.pone.0039660.g004
Figure 5. Cyclic voltammograms of DIP oxidation at the surface of glassy carbon electrode for different scan rates (a–l): 100, 200,
300, 400, 500, 600, 700, 800, 900, 1000, 1250, 1500 mVs21. Voltammograms depicted in 0.2 M phosphate buffer solution (pH 7.4) in the
absence of DIP (panel A) and the presence of 0.1 mM DIP (panel B). In the absence of DIP, no apparent cyclic voltammetric signals are observed in the
phosphonate buffer solution. DIP exhibits anodic peak at 0.5 V.
doi:10.1371/journal.pone.0039660.g005
Figure 6. The plot of oxidation peak current (I) of DIP at 0.5 V
vs. scan rates (u). It shows linear relationship between the scan rate
and the peak current of 0.1 mM DIP at the glassy carbon electrode.
doi:10.1371/journal.pone.0039660.g006
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the cation radical and Ep is the energy of the parent molecule.
Also, in this work, we investigated polar solvents effects on the
electronic structural properties of DIP within the Onsager self-
consistent reaction field (SCRF) model using a DFT method
[28,29]. Using Onsager solvent model in water (e=80) and the
cavity radius were calculated by the Gaussian program. Onsager–
SCRF method is efficient in taking account of long-range solute–
solvent electrostatic interaction [30]. The molecular energy in
water consists of (U, RO)B3LYP/6-31G(d)-calculated SPE energy.
All of the quantum-chemical calculations were carried out using
Gaussian 98 program [31].
Results
Production of stable DIP
N radical
DIP molecules were reacted with cumene hydroperoxide (CHP)
in the presence of iron (II) ions which stimulate radical generation
known as Fenton’s reaction method [21]. The iron metal has a
strong catalytic power to generate highly reactive hydroxyl radicals
(
NOH). After addition of the iron and CHP, they will react together
generating some hydroxyl radicals as:
(1) Fe




When mixing the reactants, the solution shows an EPR
spectrum (Figure 2) denoting generation of DIP
N radical. Free
radicals are generally very reactive and unstable structures because
of having an unpaired electron that temporarily disappear by
reacting with each other or substrates in the presence of liquids.
Accordingly, it is really hard to trace free radicals in solution.
Hence, the only way to detect the intermediate DIP
N radical in the
oxidant condition is practically possible for the long living stable
DIP
N radical. The production relatively stable free radical, DIP
N,
denotes that DIP
N has no tendency to react with other substrates in
solution. This excellent property should give effective chain-
breaking antioxidant activity for DIP in biological environment




The structure of DIP, shown in Figure 1, presents a stable
hetero-aromatic double ring core, which is responsible for the
characteristic UV-Vis absorption. The spectroscopic behavior of
DIP through the absorbance studies confirmed the result of EPR.
In the spectral range between 320–720 nm, two bands including
418 nm and 442 nm are observed for DIP in the absence of
DPPH
N radical (Figure 3). The change of bands’ shape was
concomitant with adding DPPH
N radicals. Data in Figure 3
indicated the intensity of second band (442 nm) which got
increased to be equal with the first band (418 nm) in the presence
of DPPH
N. Moreover, during the incubation periods (0 to 20min),
the intensity of the bands (418 and 422 nm) increased. These data
indicated the creation of a new compound that we detected by
EPR (Figure 2). Therefore, the change of bands’ shape with
increasing of the absorbance intensity of the bands during
incubation of DIP with DPPH
N denote the production of stable
DIP
N radicals.
Figure 7. Intracellular ROS determination by DCF method.
Samples were first incubated (30 min) with different concentrations of
DIP; a:0.0, b:0.25, c:0.5, d:1.0 mM. The changes of fluorescence intensity
were monitored for the following intracellular ROS. The fluorescence
behavior of the samples was monitored by excitation at 498 nm and
emission 530 nm. Samples were induced to produce intracellular ROS
and radical generator by adding the ROS stimulating agent of cumene
hydroperoxide (CHP) that was mentioned by arrow. The final
concentration of CHP was 300 mM by adding 10 mL of CHP in the final
volume of 1 mL.
doi:10.1371/journal.pone.0039660.g007
Figure 8. Cell viability against cytotoxic effect of CHP using
MTT assays. L-6 myoblasts exposed to cumene hydroperoxide (CHP)
after 30 min treatment of cells with different concentration of DIP (0, 10
and 25 mM). Control refers without any addition of DIP and CHP. No
detectable toxic effect on cell viability has been recorded for DIP in
different concentrations.
doi:10.1371/journal.pone.0039660.g008
Table 1. Ionization potentials (IPs) of DIP and trolox (Tox).
Compound IP (kcal/mol) DIP
a (kcal/mol)
DIP(gas phase) 132.00 251.99
DIP(water effect) 131.77 252.22
Tox 152.10 231.99
Parameters have been computed using B3LYP/6-31G(d)//AM1 method without
and with solvent (water) effect. The molecular geometries were first optimized
in gas phase then the solvent effect has been estimated in the frame of Onsager
model to calculate the single-point energy.
aRelative to 184.09 kcal/ mol for
phenol in the same basis set.
doi:10.1371/journal.pone.0039660.t001
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Evaluation of electron donating basically gives clear insights into
reducing potency of antioxidants against oxidative agents. This
method is based on the ability of the DIP to reduce Fe
3+ to Fe
2+.
Since reduced ferrous ion is green in color, increased reducing
power of the sample causes the absorbance of the mixture to be
increased at 700 nm. Figure 4 shows that there is good correlation
between DIP concentrations and amounts of reduced Fe
3+ in
phosphate buffered solution. Data obviously indicated a higher
electron donating ability for DIP than trolox (the water-soluble
vitamin E analogue). Hence, DIP has an electron donating
capacity which is active in polar phosphate buffer medium. These
findings propose that DIP should be active in polar intracellular
location in order to suppress high active ROS compounds (see
next sections).
Electrochemical oxidation of DIP
In order to confirm the reliability of the previously described
assessment of electron donating potency of DIP, in this part, the
electrochemical oxidation of DIP in phosphate buffer has been
studied using cyclic voltammetry. Cyclic voltammetry is a widely
used electroanalytic technique that allows the redox properties of
molecules such as antioxidants in a solution to be determined [32].
Figure 5 is a repetitive cyclic voltamperogram for DIP, recorded
for the large range of scan rates. No apparent cyclic voltammetric
signals were observed in the phosphonate buffer solution in the
absence of DIP for the different scan rates. As shown in Figure 5,
the DIP compound exhibits clearly anodic oxidation peak
potential (,0.5 V) in phosphate buffer (pH 7.4). Electro-oxidation
technique can be used for evaluating the electron-donating
capacity of the molecule. Therefore, anodic low oxidation peak
potential of DIP indicates the easily electron donating potency of
this compound.
Peak currents (I) vs. scan rates (u) give useful information about
both phenomena including: diffusion controller or adsorption
controller of oxidation process of solutes by electrode. Figure 6
shows the plot of anodic peak current of linear sweep voltammetry
vs. scan rates. The linearity of plot in the range of 100–
1500mVs
21 indicates that the oxidation of DIP at the glassy
carbon electrode is rather an adsorption-controlled than a
diffusion controlled process.
Intracellular ROS protection potency of DIP
L-6 myoblasts were used as an in vitro cell model to investigate
the intracellular efficiency of DIP as a protective agent against
ROS damage. These cells are good candidates and easy to use as
an in vitro model for testing the ability of different types of
antioxidants to scavenge intracellular ROS via DCF method
[21,33]. DCF method was used to detect levels of intracellular
ROS compounds in myoblasts treated by oxidative stressor
cumene hydroperoxide (CHP). CHP is one of the oxidizing agents
used as an intracellular source of reactive oxygen intermediates
[34]. As shown in Figure 7, DIP intercepts intracellular ROS
compounds such as hydroxyl, superoxide or other peroxide-
forming radicals, and eventually prevents the DCF fluorescence
intensity. CHP easily permeates through the cell membrane
which, in the absence of DIP, causes DCF oxidation and its
fluorescence intensity increment, whereas, DIP suppresses the
ROS generation inside the cells.
Antitoxic potency of DIP. Antitoxic property of DIP, based
on the protection of viable myoblasts against cytotoxic and lethal
effects of CHP, was evaluated using MTT assay. CHP has been
frequently used as a model compound to study both the organic
hydroperoxides and the mechanisms driving oxidative cell injury
in mammalian cells [21,34]. For this purpose, cells were treated
with different concentrations of DIP and then stimulated by CHP
as a strong toxic organic hydroperoxide molecule. The highly
ROS generating ability of CHP caused the compound to be
vigorously toxic and lethal for myoblast cells (Figure 8). DIP helps
to counteract the toxic effect of CHP.
Computational IP data
Ionization potential (IP) correlates with the ability of the
antioxidant to donate electrons. Low ionization potential (IP)
values favorably raise the electron-transfer reactivity, while high IP
values decrease the electron-transfer rate between antioxidant and
free radicals. Table 1 refers that DIP has very low IP (,132.0
kcal/mol) not only in gas phase but also in water solvent. Solvent
effect has been estimated in the frame of Onsager reaction field
model. The present results do support the more newly report on
the excellent antioxidant activity of DIP compared to its 4 different
derivatives based on the IP value of 132.16 kcal/mol [35]. It is
interesting to note that the IP value of DIP is 20 kcal/mol, less
than that of trolox. It means that DIP is much stronger electron-
donor resulting its higher antioxidant activity compared to trolox
and also confirms the experimental results of Figure 4.
Discussion
During the oxidation process, the wide range of molecules,
particularly lipids (RH), are easily oxidized to peroxyl radicals
(ROO










Reaction 3 happens very fast while reaction 4 is much slower
and forms a chain reaction. Antioxidants such as DIP are just able
to block the slower reaction (reaction 4) and are known as radical
‘‘chain-breaking antioxidant’’, accordingly;
Figure 9. Optimized structure of dipyridamole. Atomic charges
indicated by colors in the range of 20.6 (red) to +0.6 (green).
doi:10.1371/journal.pone.0039660.g009
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N can react with other stable substances
such as RH or with reactive unstable free radicals such as ROO
N,
R
N and even itself (DIP
N). If the DIP
N radical was stable and
nonreactive, it would partly react with other free radicals such as
peroxyl/alkyl/DIP






N] R ROO-DIP [R-DIP, DIP-DIP]
(non radical yield).
Therefore, a good chain-breaking antioxidant must create long
living nonreactive radical lacking invasive effects on other RH
substrate. Producing and identifying DIP
N radicals by EPR and
UV-Vis techniques (Figure 2&3) indicated its reasonable stability
as to be an effective ‘‘chain-breaking antioxidant’’. So, it may not
react or may have slow reaction with substrates such as RH or
ROOH. Therefore, the capability of cardiovascular drug DIP to
produce long living DIP
N during free radical scavenging process
suggests superb antioxidant activity for DIP with the least side
effects towards biological substances such as cellular components.
However, the action mechanism of DIP to scavenge free
radicals is still unclear. To consider the main mechanism for
radical scavenging we have focused on the quantum mechanical
calculations at the B3LYP theory level. The optimized 3D
structural geometry of DIP is displayed in Figure 9. As expected
from the crystal structure data [36], the pyrimido [5,4-d]
pyrimidine system is planar (see Figure9). Moreover the piperidine
nitrogens including N(41) and N(91) as well as the amine nitrogens
N(ll) and N(61) with their substituents C(12), C(15) and C(62),
C(65), respectively, are planer [36]. Our optimized structure
confirmed this important planer property of DIP as is indicated by
bond length and torsion angles around the N bonds (Table 2). Also
the capability of forming an intramolecular hydrogen bond O(14)-
H(14)... N(2) was compatible with crystal structure as well as with
Borges et al. quantum mechanical findings [35] (see Table 2).
These data indicate that our optimization is reliable to energy
minimization for antioxidant parameters evaluation. It is believed
that the phenolic aromatic antioxidants (ArOH) act primarily via
hydrogen atom transfer (HAT) to reduce free radicals because of
carrying a labile O-H groups [37];
(7) ROO
N + ArOH R ROOH + ArO
N (direct hydrogen-
transfer).
Considering the chemical structure of DIP in Figure 1, the
mechanism of HAT is not conceivable. DIP does not have any
phenolic labile O-H moiety while it has four ethanolic O-H
groups. Second remarkable antioxidant mechanism is proton-
coupled electron-transfer (ET). In this way, DIP
+N is produced by
electron transfer followed by deprotonation in solution to give the
corresponding DIP
N radical. At first view, this mechanism is
Table 2. Some chosen geometrical parameters including H bonding, bond angles and relevant torsion angles for 3D structure of
DIP. Calculated parameter values using AM1 were compared with computation PM3//B3LYP/6-31G* values by Borges et al. [35], as
well as crystal X-ray [36].
Parameters AM1 PM3//B3LYP/6-31G* [35] Crystal Structure [36]
Hydrogen bonding (A6)
O(14)–H(14)???N(2) 2.569 2.590,1.923 2.778, 2.829
Bond angles (Deg.)
N(2)–C(1)–N(11) 118.5 118.3,118.0 119.2, 117.7
N(10)–C(1)–N(11) 117.1 - 114.2, 116.4
C(1)–N(2)–C(3) 117.3 - 116.5,115.5
N(2)–C(3)–C(4) 121.3 121.1,120.9 121.4, 120.7
N(2)–C(3)–C(8) 123.19 - 121.3, 123.6
C(4)–C(3)–C(8) 115.4 - 116.3, 115.5
C(3)–C(4)–N(5) 120.7 - 119.9, 120.5
C(3)–C(4)–N(41) 118.40 121.7, 21.6 122.2, 122.1
N(7)–C(6)–N(61) 117.10 118.6, 116.3 115.5,114.5
C(62)–N(61)–C(65) 116.0 116.6, 120.6 120.4, 120.8
C(12)–N(11)–C(15) 116.0 116.4,119.2 119.8, 120.2
C(42)–N(41)–C(46) 112.7 112.7, 112.9 112.3, 113.1
C(92)–N(91)–C(96) 112.7 112.7,112.9 113.6, 112.7
Dihedral angle (Deg.)
N(2)–C(1)–N(11)–C(12) 11.0 10.3, 22.6 27.3, 9.8
N(10)–C(1)–N(11)–C(15) 225.8 222.0, 21.7 21.9, 20.7
N(5)–C(6)–N(61)–C(65) 225.7 16.1, 24.0 1.3, 1.5
N(7)–C(6)–N(61)–C(62)1 1 214.5, 22.3 1.8, 21.6
N(11)–C(12)–N(13)–C(14) 2124.6 2117.5, 286.8 273.6,74.4(2167.5)
N(11)–C(15)–C16)–C(17) 2177.5 274.9, 263.6 260.0, 69.7
C(3)–C(4)–N(41)–C(42) 73.5 65.6, 47.5 50.2, 251.2
C(8)–C(9)–N(91)–C(96) 73.5 66.5, 30.4 51.1, 252.4
N(8)–C(9)–N(91)–C(92) 2153.00 2156.7, 2169.4 2159.9, 163.4
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enabling deprotonation.
(8) ROO
N+ DIP R ROO
2 + DIP
N+ RROOH + DIP
N (proton-
coupled ET).
ET mechanism involves ionization potential (IP) value for
chain-breaking antioxidant activity. Calculation of DIP value
(IPcompound –I P phenol) confirmed that the electron transfer
mechanism is responsible for radical scavenging activity of DIP.
Wright et al. already showed below DIP=236 kcal/mol, the
mechanism is dominated by HAT, but for DIP above that point,
reactions tend to be predominantly ET [37]. Table 1 shows that
DIP significantly has larger DIP, which is more than 1.4 times
above the point needed for possible appearance of ET mechanism.
Thus, DIP has IP that brings certainly this molecule into the range
where ET mechanism can become important. Also, Table 1 shows
that DIP is significantly a better antioxidant, with DIP larger than
trolox. Moreover to confirm these findings, additional calculations
have been done. To analyze the possibility of HAT mechanism we
have computed H atom abstraction from ethanolic OH groups.
The optimized structures with relative DFT energies are displayed
in Figure 10. Molecular energies suggest that the elimination of the
ethanolic H atom from O-H will be a difficult process compared to
electron and following H
+ hydrogen donation. In fact, the bond
dissociation energy for direct ethanolic H atom from O-H groups
is higher than the electron transferring and following H
+ hydrogen
donation from DIP. Interestingly, electron-transfer process is
easier with the lowest barrier energy. Therefore, direct hydrogen-
transfer to reduce free radicals is not a favorable process, as this
leads to the formation of DIP
N with high barrier energy. However
electron-transfer process is favorable, as this leads to the formation
of a very stable DIP
N+ radical. Finally, this process facilitated
proton donating via proton-coupled electron-transfer mechanism
as indicated in Figure 10. These findings also support the ET
mechanism that was discussed above based on DIP value.
Furthermore, both the ferric ion reduction and electrochemical
oxidation methods are general indicators for electron-transfer
reactions that demonstrated ET feasible from DIP to reduce free
radicals. These experimental findings in aqueous solution
confirmed computationally-acquired lower IP value for DIP that
indicates the high ET capacity of DIP. Hence, the proton-coupled
ET mechanism should be mainly the radical scavenging mecha-
nism of DIP drug that contributes to the ‘‘chain-breaking
antioxidant’’ activity of DIP (Eq. 8). This process involves the
production of long lived stable DIP
N radical. Also, the cell
protection by DIP against peroxide-forming radicals and reactive
ROS compounds, can be explained by easily production of stable
DIP
N radical under the oxidant condition. Easy generation of
stable DIP
N radicals demonstrates occurrence of two important
phenomena in biological conditions driven by DIP drug;
First, DIP can easily suppress more active free radicals such as
ROO
N at different oxidative condition of human body to generate
stable DIP
N by proton-coupled ET reaction (Eq. 8). Second,
because of the stability of DIP
N radicals, these compounds are
nonreactive enough to react with biological molecules such as
lipids or protein and nucleic acids. We believe that the generated
intermediate DIP
N radicals are noninvasive for the cells. The MTT
assays based on the antitoxic potency of DIP, confirmed this
property of DIP in myoblast cells. It is possible to conclude that the
ROS scavenging and antitoxic capabilities of DIP are progressed
based on the proton-coupled electron-transfer mechanism. The
Figure 10. Structure and relative energies of DIP as well as its different derivative radicals. DIP
N+ involves cation radical that derived from
electron transfer, DIP
N is final radical involves proton donation (left geometry) and radical derived H atom abstraction via direct HAT reaction (right
geometry).
doi:10.1371/journal.pone.0039660.g010
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long lived DIP
N radicals that culminate in dose-dependency of the
drug to protect myoblast cells.
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